Science & Technology

科學技術

研究進程

Inflammasome activation blocker
Janus kinase inhibitor
  • Mode of Action

    Preclinical

    Phase I

    Phase II

    Phase III

    NDA

  • AC-1101 Granuloma Annulare

    Preclinical

    Phase I

    Phase II

    Phase III

    NDA

  • AC-1101 Atopic Dermatitis

    Preclinical

    Phase I

    Phase II

    Phase III

    NDA